Phoreus Biotechnology
Phoreus Biotechnology, Inc. is the provider of two proprietary technology platforms with the capacity to revolutionize precision delivery of the next generation of genetic vaccines and therapeutics. Our Branched Amphipathic Peptide Capsules™️️ (BAPC™️️) and Corralling Amphipathic Peptide Colloids™️️ (CAPC™️️) offer substantially increased efficacy in the creation and delivery of novel vaccines, cancer therapies, conventional small molecules and biopesticides for improved human, animal, plant and environmental health around the world. Phoreus technology will improve thermostability of fragile nucleic acid components, potentially eliminating expensive cold chain storage requirements for these revolutionary new vaccines and therapeutics.
Learn how our technology works below.